Dow up 0.46% Nasdaq up 0.21%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow up 0.46% Nasdaq up 0.21%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
12:54pm EDT 28.555 +0.015 +0.05% 28.08 28.58 9,093,537 5,434,500 73.983B Sparkline Chart Chart, News, Stats, Options, Board
{"s" : "azn","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod Zacks09:25am EDT
New Data Shows Frequent ICU Admissions from Severe RSV Disease among Preterm Infants in the First Three Months of Life Business Wire08:00am EDT
Thursday October 27, 2016
PRESS DIGEST- Financial Times - Oct 28 Reuters08:23pm EDT
[$$] FDA deals blow to AstraZeneca cancer drug at Financial Times02:11pm EDT
[$$] AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials at The Wall Street Journal01:14pm EDT
[$$] AstraZeneca slides after cancer drug trial suspended at Financial Times12:56pm EDT
AstraZeneca PLC (ADR) (AZN) Unveils Positive SOLO-2 Data at Insider Monkey10:02am EDT
Wednesday October 26, 2016
Tesaro's Ovarian Cancer Drug Has Edge Vs. AstraZeneca's: Analyst at Investor's Business Daily04:36pm EDT
AstraZeneca Is Now a Competitive Threat to Tesaro in Ovarian Cancer Maintenance Therapy at TheStreet07:40am EDT
Puts showing caution in AstraZeneca optionMONSTER07:16am EDT
Myriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib GlobeNewswire07:15am EDT
LYNPARZATM (olaparib) Phase III SOLO-2 Trial Shows Significant Progression-Free Survival Benefit Business Wire07:00am EDT
3:47 am AstraZeneca reports positive results in Lynparza trial; shows significant progression-free survival benefit Briefing.com03:47am EDT
Monday October 24, 2016
Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans PR Newswire08:05am EDT
Friday October 21, 2016
Here's how a $50 drug ends up costing you $700 in America's healthcare system Business Insider11:01am EDT
Thursday October 20, 2016
Cloud-Centered IT Transformation At AstraZeneca at Forbes10:00am EDT
Wednesday October 19, 2016
Drug Wars: California Vote Could Limit Price Hikes at Investopedia01:19pm EDT
AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted Zacks09:56am EDT
Tuesday October 18, 2016
AstraZeneca Plc : AZN-US: Dividend Analysis : August 12th, 2016 (record date) : By the numbers : October 18, 2016 at Capital Cube12:39pm EDT
Monday October 17, 2016
White House To Announce Big Push For Cancer Blood Tests at Forbes07:30am EDT
Saturday October 15, 2016
How the Opioid Epidemic Is Changing 2 Drugmakers' Fortunes at Motley Fool05:11pm EDT
Friday October 14, 2016
AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas at Insider Monkey02:28pm EDT